uniQure (QURE) Payables (2015 - 2026)
uniQure (QURE) recorded quarterly Payables of $3.6 million in Q1 2026, down 35.51% quarter-over-quarter from $5.5 million in Q4 2025, and up 125.44% on a YoY basis from $1.6 million in Q1 2025.
uniQure (QURE) Payables (2015 - 2026) Analysis & Trends
uniQure's Payables history runs 12 years deep, the most recent figure standing at $3.6 million for Q1 2026.
- In Q1 2026, Payables rose 125.44% year-over-year to $3.6 million; the TTM figure through Mar 2026 stood at $3.6 million (up 125.44% YoY), while the FY2025 annual figure was $5.5 million, up 11.55% from the prior year.
- Payables was $3.6 million for Q1 2026 at uniQure, down from $5.5 million in the prior quarter.
- In the past five years, Payables ranged from a high of $11.0 million in Q4 2022 to a low of $771000.0 in Q2 2023.
- Historically, Payables has averaged $5.4 million across 5 years, with a median of $5.4 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Payables jumped 339.01% in 2022, then plunged 92.31% in 2023.
- A 5-year view of Payables shows it stood at $11.0 million in 2022, then tumbled by 87.25% to $1.4 million in 2023, then soared by 253.64% to $5.0 million in 2024, then grew by 11.55% to $5.5 million in 2025, then plunged by 35.51% to $3.6 million in 2026.
- The last three Payables figures came in at $3.6 million (Q1 2026), $5.5 million (Q4 2025), and $3.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 3.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | 5.52 Mn |
| Sep 30, 2025 | 3.60 Mn |
| Jun 30, 2025 | 5.54 Mn |
| Mar 31, 2025 | 1.58 Mn |
| Dec 31, 2024 | 4.95 Mn |
| Sep 30, 2024 | 5.44 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 5.23 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 5.58 Mn |
| Jun 30, 2023 | 771,000.00 |
| Mar 31, 2023 | 8.89 Mn |
| Dec 31, 2022 | 10.98 Mn |
| Sep 30, 2022 | 7.57 Mn |
| Jun 30, 2022 | 10.03 Mn |
| Mar 31, 2022 | 9.92 Mn |
| Dec 31, 2021 | 2.50 Mn |
| Sep 30, 2021 | 5.37 Mn |
| Jun 30, 2021 | 16.82 Mn |